Back

Current prevalence and remaining challenges of sodium-glucose cotransporter 2 inhibitors in patients with heart failure

European Heart Journal - Quality of Care and Clinical Outcomes

17 April 2026
Organised by: Logo
Read full article
ESC Journals HEART FAILURE Chronic Heart Failure

Contributors

Akito Nakagawa
Akito Nakagawa

Author

Amagasaki Chuo Hospital Amagasaki , Japan

You may be interested in
thumbnail
Congress Presentation
Sodium glucose cotransporter 2 inhibitors eligibility in patients with heart failure across the spectrum of ejection fraction
23 May 2022
thumbnail
Congress Session
The power of now: a focus on SGLT2 inhibitors for heart failure in the hospital
17 May 2025
thumbnail
Congress Presentation
Guideline directed medical treatment and comorbidity burden among patients admitted with acute HF decompensation: insights from the HECMOS 2.0
30 August 2025
thumbnail
Congress Session
Innovative drug therapies in heart failure
18 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources